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Introduction   
   
Inflammatory hyperplasia is a low-intensity local response of tissue to injury 
associated with the use of ill-fitting prosthesis. It is generally characterized by single or 
multiple, sessile or pedunculated tissue growth located on the palate or vestibule of 
the mouth. Treatment is based on removal of etiologic agent and excision of the 
lesion by conventional surgery (surgical knife), electrosurgery, abrasion, or cryotherapy 
(1-3).
 
Cryotherapy is an effective method of tissue destruction by means of freezing 
and has been used in the treatment of several lesions, such as pyogenic granuloma, 
actinic cheilitis, leukoplakia, vascular lesion, mucocele, keratoacanthoma, and 
papillomatous hyperplasia of the palate (4-12). The available cryotherapy apparatus is 
classified into open and closed systems. Open systems involve the direct application of 
the cryogenic fluid (usually liquid nitrogen) to the lesion with a cotton swab or spray. 
In closed systems the tissue is frozen by a cryoprobe (11,13-15).  
 
The combination of direct (rapid buildup of toxic electrolyte concentrations, 
pH alteration, protein denaturation, and direct disruption of cell membranes) and 
indirect (vascular and immunological effects) cellular effects can lead to tissue death 
(4-7,14,15,17). 
 
Cryotherapy has some advantages, such as absence of bleeding, low incidence 
of secondary infection, minimal scarring and pain, and low treatment cost (4-9,18,19). 
However, reports in the literature refer to many different generalized protocols, usually 
based on “self-experience”, thereby leading to questions on how to best use 
cryosurgery.  
 
 
   IJCDS • FEBRUARY, 2011 • 2(1) © 2011  Int. Journal of Clinical Dental Science 
 
 
 
 
 
 
 
ABOUT THE AUTHORS 
1.Hedelson Odenir Iecher 
Borges,                DDS, PhD 
Department of Oral and 
Maxillofacial Traumatology 
and Surgery, School of 
Dentistry, Pontifícia 
Universidade Católica do Rio 
Grande do Sul, Brazil  
 
2.Etiene de Andrade 
Munhoz,               DDS, PhD 
Department of Conservatory 
Dentistry, Oral Pathology, 
School of Dentistry, 
Universidade Federal do Rio 
Grande do Sul, Brazil.  
 
3.Rosilene Andrea Machado,    
                                 DDS, PhD  
Department of Oral and 
Maxillofacial Traumatology 
and Surgery, School of 
Dentistry, Pontifícia 
Universidade Católica do Rio 
Grande do Sul, Brazil  
 
4.Daniela Nascimento Silva,  
                                 DDS, PhD 
Department of Oral and 
Maxillofacial Traumatology 
and Surgery, School of 
Dentistry, Pontifícia 
Universidade Católica do Rio 
Grande do Sul, Brazil  
 
5.Marco Antonio Trevizani 
Martins,                   DDS, PhD 
Department of Conservatory 
Dentistry, Stomatology, School 
of Dentistry, Universidade 
Federal do Rio Grande do Sul, 
Brazil.  
 
6.Manoel Sant’ana Filho,  
                                 DDS, PhD 
Chairman of the Postgraduate 
program Oral Pathology, 
School of Dentistry, 
Universidade Federal do Rio 
Grande do Sul 
 
Corresponding Author:  
 
Manoel Sant’Ana Filho 
Universidade Federal do Rio 
Grande do Sul 
Department of Oral Pathology 
Ramiro Barcelos 2492/sala 503  
CEP 90035-003 
Faculdade de Odontologia 
Porto Alegre, RS, Brazil. 
Tel/Fax: 55 51 
33085011/33085023 
e-mail: manoel@ufrgs.br   
 
 
 
Abstract      
                         
Aims & Objectives: The aim of this study was to evaluate a protocol for clinical use of 
cryosurgery in the treatment of oral inflammatory hyperplasia. Trans and postoperative pain 
and duration of surgery were also assessed.  
Methods: Twelve patients underwent liquid nitrogen cryotherapy with a closed probe. Two 
60-second treatment applications were performed, and thawing was allowed to proceed for 2 
minutes. 
Results: Cure of hyperplasia was achieved in six patients (successful group), whereas three 
patients had no decrease in the size of the lesion (unsuccessful group). Three patients did not 
return for follow-up.  
Conclusion: It is possible to conclude that cryosurgery is an effective therapy for up to 12-
mm long pedunculated hyperplasias and can be considered an alternative, useful, fast and 
painless method for treatment of inflammatory hyperplasia.  
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The objective of this study was to establish an efficient 
protocol for use of liquid nitrogen cryotherapy with 
closed probes in the treatment of inflammatory 
hyperplasia by assessing trans and postoperative pain 
as well as efficacy and clinical success of the proposed 
protocol.  
 
Materials and Methods 
Study design 
This case-control study included volunteers 
aged 50 to 62 years, according to the following criteria: 
clinical presentation of inflammatory hyperplasia with 
compatible clinical history, presence of causal agent 
(removable complete denture), and absence of clinical 
signs of candidiasis, ulcer and erythroplasia. The 
lesions were clinically diagnosed and measured 
approximately 5.5 x 3.5 cm. The final sample (n=12) 
was composed of two men and 10 women. 
The protocol was approved by the Institutional 
Review Board, and written informed consent was 
obtained from all patients.  
 
Surgical procedure 
Before surgery, all lesions were photographed 
with a Sony F717 digital camera (Sony Inc., Tokyo, 
Japan) in a standardized manual mode and measured 
using a digital caliper (Mitutoyo®; Mitutoyo Corp., 
Suzano, SP, Brazil) to determine the highest lesion 
diameter and, therefore, the number of application 
sites (1 to 5). 
All procedures were performed on an 
outpatient basis. No anesthesia was required. The 
lesions were treated by direct application of liquid 
nitrogen using the CRY-AC®-3 #B-700 storage device 
adapted to a 6-mm closed probe #215 (Brymill 
Cryogenics Systems, Connecticut, USA) for 60 seconds 
until an ice-ball has formed. This procedure was 
repeated and overlapping freezes were used for larger 
lesions. Spontaneous thawing was allowed to proceed 
for 2 minutes between two consecutive freeze-thaw 
cycles. This protocol is based on that of Beltrão.
20
 
Data on clinical aspects, lesion site and size, 
and duration of surgery were recorded. Duration of 
surgery was measured from the beginning of the first 
cycle until the end of the second cycle of the last 
application site. 
 
Clinical response and assessment of trans and 
postoperative pain 
The patients were asked to record their pain 
severity during the procedure and on the 7th 
postoperative day on an 11-point pain intensity 
numerical rating scale ranging from 0 = no pain to 10 
= unbearable pain. A secondary treatment was 
performed after two weeks if necessary. If any residual 
lesion remained after two treatment sessions, with no 
decrease in size, the patient was referred to 
conventional treatment.  
After a 14-day follow-up period, the lesions 
were again photographed and a clinical evaluation was 
performed according to the following criteria:  
- Unsuccessful: absence of lesion regression 
or clinical alteration after two procedures. 
- Successful: lesion regression or some 
clinical alteration with the need for 
complementary procedure. 
 Patients were recalled two months after 
cryosurgery for evaluation of absence of lesion 
recurrence. 
 
Results 
Clinical response 
From the initial sample of 12 patients, three 
did not attend all follow-up examinations due to 
change of address and/or telephone number or refusal 
to participate. Of the remaining patients, six had 
successful treatment (Figure 1) and three had 
unsuccessful results. Patients in the successful group 
had pedunculated lesions up to 12 mm in length. In 
the unsuccessful group, patients had sessile lesions 
ranging from 9 to 25 mm in length. Data regarding 
lesion shape, site and size, number of procedures, and 
clinical evaluation are summarized in Table 1. 
The mean duration of surgery was 6 to 10 
minutes in most cases (43.5%), followed by 11 to 15 
minutes (30.5%). 
 
Transoperative pain 
During the procedure two patients (16.66%) 
reported some pain (a score of 2 in the 11-point 
numerical rating scale for pain), but no anesthesia was 
required. Data regarding transoperative pain are 
summarized in Table 2. 
 
Postoperative pain 
For most patients, postoperative pain, if 
present, was usually mild (a score ≤ 2 in the 11-point 
numerical rating scale for pain) and easily controlled 
with medication. 
Among patients reporting pain, 89.76% 
reported pain within the first 24 hours of surgery: most 
patients rated pain as 1 (48.80%), followed by a score 
of 2 (44.20%) (Table 1). On the second postoperative 
day, 6.8% of patients rated pain as 1 or 2; on the third 
postoperative day, 3.44% rated pain as 1 or 2. After this 
period, all patients reported no pain. 
According to the pain scores recorded by 
patients, pain was minimal and tolerable: a score of 1 
was the most frequently recorded (n=21, 48.8%), 
followed by 2 (n=19, 44.20%), 3 (n=2, 4.7%), and 5 
(n=1, 2.3%). Data regarding postoperative pain are 
summarized in Table 2. 
 
Discussion 
Cryotherapy is the deliberate destruction of 
tissue by application of extreme cold and has been 
used in oral medicine and pathology for over 30 years 
(5). Reports of tissue destruction by freezing date back 
to the British physician, Arnott in 1851 (5). Initially, its 
use was limited to the treatment of cancer of the lip 
and oral cavity. At present, cryotherapy has a wide 
application in the treatment of both benign and 
malignant lesions in the head and neck region. In fact, 
over 40 different dermatological conditions of the 
head and neck have been described as being 
amenable to cryotherapy (5). It is worth mentioning 
that cryotherapy should be indicated to clinically  
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Patient Age Sex Shape Site Size 
(mm) 
Number of 
procedures 
Clinical 
evaluation 
1 45 M Pedunculated Maxillary alveolobuccal sulcus 09 5 Successful 
2 64 F Pedunculated Maxillary alveolar ridge 03 1 Successful 
Sessile Palate 03 2 Successful 
3 58 F Pedunculated Buccal mucosa 04 1 Successful 
4 62 F Pedunculated Mandibular alveolobuccal sulcus 09 2 Successful 
5 67 F Pedunculated Mandibular alveolobuccal sulcus 12 6 Successful 
6 53 F Pedunculated Maxillary alveolar ridge 12 6 Successful 
7 65 F Sessile Mandibular alveolar ridge 25 2 Unsuccessful 
8 49 F Sessile Maxillary alveolar ridge 09 2 Unsuccessful 
9 56 F Sessile Maxillary alveolar ridge 12 2 Unsuccessful 
 
 
 
 
 
 
Pain (numerical scale) Transoperative Postoperative 
0 83.33% ---- 
1 ----- 48.8% 
2 16.66% 44.2% 
3 ----- 4.7% 
4 ----- ----- 
5 ----- 2.3% 
 
 
 
 
Table2: Scores on pain intensity during and after cryosurgery 
 
Table1: Patient profile data, lesion shape, site and size, number of procedures, and clinical evaluation of a 
protocol for use of cryotherapy in the treatment of inflammatory hyperplasia 
 
Figure 1: Preoperative (A) and postoperative (B) image of pedunculated lesion in a successful group of 
cryotherapy patients. 
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diagnosable lesions, such as hemangioma and 
inflammatory hyperplasia, the lesion investigated in 
this study. For other oral lesions, such as leukoplakia, 
actinic cheilitis, and keratoacanthoma, incisional biopsy 
is imperative and can often serve as a treatment, 
cryotherapy being indicated to larger lesions after 
histopathological diagnosis. 
Studies have shown the effective use of 
cryotherapy in a variety of soft tissue lesions affecting 
the oral cavity (11,12,21,22). However, an established 
protocol for different lesions is lacking, as well as a 
description of the events and symptoms that occur 
during the healing process; aspects evaluated in this 
study.  
Current protocols suggest that for most benign 
oral mucosal lesions a 1–2 minute freeze-thaw cycle 
using a cryoprobe is sufficient. For smaller lesions, 
shorter freeze cycles (20–30 seconds) are adequate. In 
cases where hyperplastic tissue exists, freezing of the 
mass and then removing the bulk of tissue, followed by 
further freezing of the tissue base results in higher 
success rates.  
A number of authors have reported the use of 
cryotherapy to treat oral hyperplasia (4,6,10,13,23,24).
 
Nevertheless, none of them determined criteria for the 
indication of cryotherapy, thus hindering the 
reproducibility of the protocols. In the present study, 
hyperplasia with a pedunculated base, measuring up to 
12 mm in length, showed good response to 
cryotherapy. However, sessile-based hyperplastic 
lesions did not respond to treatment. The protocol 
proposed in this study, using two 60-second cycles 
with a 2-minute interval, was successful in 66.66% of 
cases (Table 1). 
Cryotherapy is well accepted by patients due 
to a relative lack of discomfort, absence of bleeding, 
and minimal to no scarring (17). Apparently, 
postoperative healing does not cause tissue retraction 
in the alveolar ridge, which is beneficial to prosthetic 
rehabilitation. Cryotherapy is a relatively painless 
procedure. This is due to the immediate blockage to 
neural transmission in the area. Within one minute of 
the thaw cycle, earliest signs of nerve damage are 
apparent. This is due to a combination of the freezing 
episode itself, as well as ischemic changes resulting in 
energy deprivation. The neuron itself is devitalized by 
freezing, but the axon sheath is resistant to freezing 
and remains intact. This allows growth of a new neuron 
and regeneration is apparent in one week. Normal 
function can be expected to return within 1–2 months. 
Some reports have addressed the use of 
anesthesia in the treatment of hyperplasia by 
cryotherapy, including topical anesthesia (7,13), local 
anesthesia (4,7,10,13,23), as well as no anesthesia at all 
(10.14.24). In the present study, patients were free to 
ask for local anesthesia during the cryotherapy 
sessions, but none of them required anesthesia.  
Some studies refer to minimal to no pain 
during cryotherapy (4,13,23). In this study, 27.58% of 
patients in all sessions reported mild surgical pain (a 
score of 2 in the numerical rating scale for pain). Yet, 
none of these patients required anesthesia.  
After surgery, little or no pain was observed in 
some studies using cryotherapy in the treatment of 
hyperplasia, which indicates that this therapy provides 
the patient with more comfort when compared to 
other therapies, such as conventional excision, laser 
ablation, and mucosal abrasion (4,8.13,23). Our results 
show that, among patients reporting pain, 89.76% 
reported pain (scores of 1 and 2) within the first 24 
hours of surgery. Therefore, clinicians should be aware 
that cryotherapy may be a practical and feasible 
method for treating inflammatory hyperplasia, in 
addition to being considered easier, more comfortable 
and more acceptable to patients. One limitation of this 
technique is the requirement for further sessions and 
greater patient compliance when treating larger 
lesions. The protocol proposed in this paper, 
considering the limitations of this study, appears to be 
effective.  
 
Conclusion 
The results obtained allow us to conclude that 
cryotherapy is an alternative, useful, fast and painless 
method for treatment of inflammatory hyperplasia. 
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